Cara Therapeutics Inc (CARA)
0.3087
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 15:54
Cara Therapeutics Max Drawdown (5Y): 99.17% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.17% |
| September 30, 2024 | 99.17% |
| August 31, 2024 | 99.17% |
| July 31, 2024 | 99.17% |
| June 30, 2024 | 99.17% |
| May 31, 2024 | 98.22% |
| April 30, 2024 | 98.22% |
| March 31, 2024 | 98.22% |
| February 29, 2024 | 98.22% |
| January 31, 2024 | 98.18% |
| December 31, 2023 | 97.96% |
| November 30, 2023 | 96.81% |
| October 31, 2023 | 96.37% |
| September 30, 2023 | 94.28% |
| August 31, 2023 | 91.20% |
| July 31, 2023 | 91.13% |
| June 30, 2023 | 90.30% |
| May 31, 2023 | 89.11% |
| April 30, 2023 | 86.54% |
| March 31, 2023 | 83.25% |
| February 28, 2023 | 74.48% |
| January 31, 2023 | 74.48% |
| December 31, 2022 | 74.48% |
| November 30, 2022 | 74.48% |
| October 31, 2022 | 74.48% |
| Date | Value |
|---|---|
| September 30, 2022 | 74.48% |
| August 31, 2022 | 74.48% |
| July 31, 2022 | 74.48% |
| June 30, 2022 | 74.48% |
| May 31, 2022 | 74.48% |
| April 30, 2022 | 70.13% |
| March 31, 2022 | 66.16% |
| February 28, 2022 | 66.16% |
| January 31, 2022 | 66.16% |
| December 31, 2021 | 66.16% |
| November 30, 2021 | 66.16% |
| October 31, 2021 | 74.30% |
| September 30, 2021 | 74.30% |
| August 31, 2021 | 76.79% |
| July 31, 2021 | 76.79% |
| June 30, 2021 | 78.93% |
| May 31, 2021 | 80.50% |
| April 30, 2021 | 80.50% |
| March 31, 2021 | 80.50% |
| February 28, 2021 | 80.50% |
| January 31, 2021 | 80.50% |
| December 31, 2020 | 80.50% |
| November 30, 2020 | 80.50% |
| October 31, 2020 | 80.50% |
| September 30, 2020 | 80.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
66.16%
Minimum
Nov 2021
99.17%
Maximum
Jun 2024
82.67%
Average
80.50%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Agilent Technologies Inc | 42.74% |
| Seelos Therapeutics Inc | 100.00% |
| Citius Pharmaceuticals Inc | 98.88% |
| Moleculin Biotech Inc | 98.40% |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -68.03 |
| Beta (5Y) | 0.6828 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 76.13% |
| Historical Sharpe Ratio (5Y) | -0.7779 |
| Historical Sortino (5Y) | -1.130 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 46.07% |